Dr. William Michael Nash, D.M.D Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 927 Deep Valley Dr Ste 220, Rolling Hills Estates, CA 90274 Phone: 310-377-5566 Fax: 310-377-5568 |
Mariam Nadi, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 3614 W Estates Ln Unit A, Rolling Hills Estates, CA 90274 Phone: 310-539-1111 Fax: 310-539-4111 |
Dr. Damien Anthony Delio Dentist - Orthodontics and Dentofacial Orthopedics Medicare: Not Enrolled in Medicare Practice Location: 827 Deep Valley Dr., #302, Rolling Hills Estates, CA 90227 Phone: 310-377-6895 Fax: 310-541-1675 |
Gregory Yin Sue, D.D.S. Dentist - Orthodontics and Dentofacial Orthopedics Medicare: Not Enrolled in Medicare Practice Location: 501 Deep Valley Dr Ste 201, Rolling Hills Estates, CA 90274 Phone: 310-377-5544 |
Eduardo F Valdes, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 550 Deep Valley Dr Ste 347, Rolling Hills Estates, CA 90274 Phone: 310-361-4535 |
Dr. Kevin T Lin, DDS Dentist Medicare: Medicare Enrolled Practice Location: 857 Silver Spur Rd, Rolling Hills Estates, CA 90274 Phone: 310-377-0966 |
David Merrick Taylor, D.D.S. Dentist - Pediatric Dentistry Medicare: Not Enrolled in Medicare Practice Location: 550 Deep Valley Dr, Suite 345, Rolling Hills Estates, CA 90274 Phone: 310-377-4551 Fax: 310-541-6042 |
News Archive
With unsurpassed value and energy efficiency, the AIM LED provides 10 times the life and uses 55 percent less energy when compared to halogen light sources. Burton Medical Products, Inc. has developed a revolutionary diagnostic and examination light, the AIM LED, by combining the smart and versatile design of their existing AIM lights with the efficiency and longevity of an LED light source.
A large study just published in the journal Anaesthesia raises important questions about the way anemia is currently managed in surgical patients (Associations of nadir hemoglobin level and red blood cell transfusion with mortality and length of stay in surgical specialties: a retrospective cohort study).
Avedro, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the Company's VibeX for use with its KXL System (UVA irradiation) for Corneal Cross-linking to treat Keratoconus.
In a study published in the New England Journal of Medicine, a research consortium that includes the University of Alabama at Birmingham (UAB) has shown that a new drug for vasculitis, a potentially life-threatening auto-immune disease which causes inflammation in blood vessels, is as effective as standard therapy over 18 months.
Gilead Sciences, Inc. today announced that detailed results from four Phase 3 clinical trials (NEUTRINO, FISSION, POSITRON and FUSION) evaluating sofosbuvir, the company's investigational once-daily nucleotide NS5B inhibitor for the treatment of chronic hepatitis C virus infection, will be presented this week in oral sessions at the 48th Annual Meeting of the European Association for the Study of the Liver in Amsterdam, The Netherlands.
› Verified 5 days ago